Effect of diltiazem on intraarterial blood pressure and heart rate during stress testing in patients with angina: A gender comparison study

Journal of Clinical Pharmacology

Volumn 37, Issue 4, 1997, Pages 297-303

  Klassen, Gerald A ^a,b   Yeung, Pollen K F ^a   Barclay, Katherine D ^a   Pollak, P Timothy ^a   Hung, Orlando R ^a   Buckley, Susan J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; GLYCERYL TRINITRATE;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PR INTERVAL; PULSE PRESSURE; SEX DIFFERENCE; ST SEGMENT DEPRESSION; TREADMILL EXERCISE;

EID: 0030967959     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04306.x     Document Type: Article

References (15)

1. Klassen GA, Yeung PFK, Barclay KD, Hung OR, Pollak PT, Buckley SJ: Gender differences in exercise and recovery blood pressure responses in normal volunteers given diltiazem. J Clin Pharmacol 1995; 35:1144-1149.
2. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR: Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994; 120:559-566.
3. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE: The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332:1758-1766.
4. Heart disease: women at risk. Consumer Reports. 1993;May: 300-304.
5. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, et al: Female sex and higher drug dose as risk factors for late cardiotoxic effects of Doxorubicin therapy for childhood cancer. N Engl J Med 1995; 332:1738-1743.
6. Kando JC, Yonkers KA, Cole JO: Gender as a risk factor for adverse events to medications. Drugs 1995; 50:1-6.
7. Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, et al, for the GUSTO-I Investigators: Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA 1996; 275:777-782.
8. Yeung PK, Montague TJ, Tsui B, McGregor C: High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers. J Pharm Sci 1989; 78:592-597.
9. Yeung PKF, Buckley SJ, Hung OR, Pollak PT, Barclay KD, Feng JDZ, et al: Steady-state plasma concentrations of diltiazem and its metabolites in patients and healthy volunteers. Ther Drug Monit 1996; 18:40-45.
10. Harris RZ, Benet LZ, Schwartz JB: Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50:222-239.
11. Kenney MJ, Seals DR: Postexercise hypotension. Key features, mechanisms, and clinical significance. Hypertension 1993; 22:653-664.
12. Cléroux J, Yardley C, Marshall A, Coulombe D, Lacourcière Y: Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise. Am J Hypertens 1992; 5:84-87.
13. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, et al: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274:620-625.
14. Buckley MM-T, Grant SM, Goa KL, McTavish D, Sorkin EM: Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Drugs 1990; 39:757-806.
15. Avolio AP, Chen S-G, Wang R-P, Zhang C-L, Li M-F, O'Rourke MF: Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983; 68:50-58.